The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Introduction to rdborrow
Matthew Secrest
2026-08-20
Overview
rdborrow implements causal inference methods for
incorporating external controls in randomized controlled trials (RCTs)
with longitudinal outcomes. The package provides tools for both analysis
and simulation, enabling researchers to evaluate different borrowing
strategies and design trials that leverage external data.
The methods are motivated by the SUNFISH trial for spinal muscular
atrophy (SMA), where external controls from the olesoxime trial augment
the randomized data to improve statistical efficiency.
Methods
Primary analysis (placebo-controlled phase)
These methods estimate the average treatment effect (ATE) during the
placebo-controlled phase by borrowing from external controls.
| EC-IPW |
ec_ipw() |
Zhou et al. (2024b) |
Inverse probability weighting with external control borrowing |
| EC-AIPW |
ec_aipw() |
Zhou et al. (2024b) |
Augmented IPW (doubly robust) |
Both methods support:
- No borrowing (
weight = 0): uses only
RCT data
- Optimal weight (
weight = NULL):
data-adaptive weight minimizing variance
- Fixed weight (
weight = 0.3):
user-specified borrowing amount
- Sandwich variance or bootstrap
inference
See vignette("primary_analysis_workflow") for usage.
OLE phase analysis (open-label extension)
After the placebo-controlled phase, control subjects cross over to
treatment. These methods estimate the long-term treatment effect using
external controls who remain untreated.
| DID-EC-IPW |
did_ec_ipw() |
Zhou et al. (2024a) |
Difference-in-differences with IPW |
| DID-EC-AIPW |
did_ec_aipw() |
Zhou et al. (2024a) |
DID with augmented IPW |
| DID-EC-OR |
did_ec_or() |
Zhou et al. (2024a) |
DID with outcome regression |
| SCM |
scm() |
Zhou et al. (2024a) |
Synthetic control method |
All OLE methods use bootstrap for inference.
See vignette("OLE_analysis_workflow") for usage.
Simulation
The simulation module evaluates estimator performance via Monte
Carlo:
simulate_trial() generates synthetic trial + external
control data
setup_simulation_primary() /
setup_simulation_OLE() configure simulations
run_simulation() runs Monte Carlo experiments and
reports bias, variance, MSE, coverage, power
See vignette("primary_simulation_workflow") and
vignette("OLE_simulation_workflow") for usage.
Getting help
The help pages for run_analysis() and
run_simulation() list all available methods and link to
their documentation:
?run_analysis
?run_simulation
Quick start
# create an EC-IPW method with optimal borrowing weight
method <- ec_ipw(ps_formula = "S ~ x1 + x2 + x3 + x4 + x5")
# set up the analysis
analysis <- setup_analysis_primary(
data = SyntheticData,
trial_status_col_name = "S",
treatment_col_name = "A",
outcome_col_name = c("y1", "y2"),
covariates_col_name = c("x1", "x2", "x3", "x4", "x5"),
method_weighting_obj = method
)
# run
results <- run_analysis(analysis)
results
## $results
## point_estimates standard_deviation lower_CI_normal upper_CI_normal
## tau1 -0.1971969 0.5134018 -1.203446 0.809052
## tau2 0.4697209 0.5410007 -0.590621 1.530063
##
## $borrow_weight
## [1] 0.1475196
References
- Zhou X, Zhu J, Drake C, Pang H (2024). “Causal estimators for
incorporating external controls in randomized trials with longitudinal
outcomes.” Journal of the Royal Statistical Society Series A:
Statistics in Society. doi: 10.1093/jrsssa/qnae075.
- Zhou X, Pang H, Drake C, Burger HU, Zhu J (2024). “Estimating
treatment effect in randomized trial after control to treatment
crossover using external controls.” Journal of Biopharmaceutical
Statistics. doi: 10.1080/10543406.2024.2444222.
- Shi L, Pang H, Chen C, Zhu J (2025). “rdborrow: an R package for
causal inference incorporating external controls in randomized
controlled trials with longitudinal outcomes.” Journal of
Biopharmaceutical Statistics, 35(6), 1043-1066. doi: 10.1080/10543406.2025.2489283.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.